Showing results (371-380 of 447) with videos related to
Sort By:
Pageof 45
Molecular Cancer Research : MCR|October 10, 2022
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung CancerShideh Mirhadi, Wen Zhang, Nhu-An Pham, et al.The Lancet. Oncology|December 3, 2014
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trialPeter M Ellis, Frances A Shepherd, Michael Millward, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2023
Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic AssessmentSanja Dacic, Xuanye Cao, Neus Bota-Rabassedas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trialCesare Gridelli, Fortunato Ciardiello, Ciro Gallo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancerMassimo Di Maio, Natasha B Leighl, Ciro Gallo, et al.The Journal of Molecular Diagnostics : JMD|December 31, 2022
CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA SequencingTracy L Stockley, Bryan Lo, Adrian Box, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver studyErik Thunnissen, Masayuki Noguchi, Seena Aisner, et al.Lung Cancer (Amsterdam, Netherlands)|July 30, 2022
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLCSally C M Lau, Madhumitha Rabindranath, Jessica Weiss, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2020
Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)Raphael Bueno, William G Richards, David H Harpole, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.Pageof 45